Company profile
LEI
cee stock exchange group
Issuers / Issuers News
Article print

13 Sep 2013 14:15 
Extraordinary Information
Marketing authorisation for biosimilar infliximab in EU
Attached documents:
Releaser: EGIS Pharmaceuticals PLC
Date Issued: 13 Sep 2013
 
Actual
2013 average
Name
Price
%
Turn. (mEUR)
ˇ
756
-2.45
0
^
189
+1.07
0
ˇ
901
-0.99
0
^
232
+1.31
0
-
5,760
0.00
0
^
895
+0.67
0
-
12,850
0.00
1
^
309
+0.65
1
^
4,328
+3.54
10
^
339
+1.19
0
^
1,310
+1.95
0
^
3,839
+2.05
2
ˇ
188
-1.05
0
^
4,060
+1.00
0
Change %: to baseprice
Data delayed by 15 minutes
Indices
Index
Value
Change %
BUX
17,702.77
294.80 (1.69)
1,518.98
3.04 (0.20)
1,207.68
7.83 (0.65)
1,192.16
7.37 (0.62)
1,847.57
2.71 (0.15)